Part 11 Subpart B - Electronic Records

Part 11 Subpart B establishes the FDA's requirements for electronic records used in clinical trials, manufacturing, and other regulated activities, mandating that such records be trustworthy, reliable, and equivalent to paper documentation. It defines controls for system validation, access authorization, audit trails, record retention, and the ability to generate accurate, permanent copies for review.